Status:
COMPLETED
Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Conditions:
Rescue Therapy for Helicobacter Pylori
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The eradication rates of first-line treatment for Helicobacter pylori(Hp) infection are not satisfactory. The study aims to compare the efficacy and safety between quadruple therapy with furazolidone ...
Eligibility Criteria
Inclusion
- Patients aged from 18 to 80 years, who presented with upper gastrointestinal symptoms and endoscopically proven H. pylori-positive non-ulcer dyspepsia, were recruited into the study.
Exclusion
- patients with peptic ulcer,
- previous H. pylori eradication treatment,
- previous gastric surgery,
- pregnancy,
- lactation,
- major systemic diseases,
- receipt of anti-secretory therapy,
- antibiotics or bismuth in the preceding four weeks, or - allergy to any one of the medications in the regimen.
Key Trial Info
Start Date :
May 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2013
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT01805934
Start Date
May 1 2012
End Date
February 1 2013
Last Update
March 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Renji Hospital
Shanghai, Shanghai Municipality, China